Stocks CSPI Financial statements
Financial statementsCSP INC /MA/ financial statements
Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CSP INC /MA/ files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 103 | 88.5 | 72.9 | 79.1 | 61.8 | 49.2 | 54.4 | 64.6 | 55.2 | 58.7 |
| Cost of revenue | 78.3 | 67.1 | 54.5 | 61 | 44.6 | 33.1 | 35.5 | 42.7 | 36.4 | 40.2 |
| Gross profit | 25 | 21.4 | 18.4 | 18 | 17.2 | 16.1 | 18.8 | 21.9 | 18.9 | 18.5 |
| Research and development | 2.98 | 2.36 | 3.28 | 2.8 | 2.8 | 2.89 | 3.08 | 3.14 | 2.96 | 3.25 |
| Selling, general and administrative | 18.3 | 15.7 | 16.7 | 16.1 | 15.8 | 14.6 | 15.8 | 16.9 | 17.8 | 18.4 |
| Operating expenses | 21.2 | 18 | 20 | 18.9 | 18.6 | 17.5 | 18.9 | 20.1 | 20.7 | 21.6 |
| Operating income | 3.8 | 3.4 | -1.6 | -0.83 | -1.42 | -1.36 | -0.04 | 1.87 | -1.87 | -3.11 |
| Interest expense | 0.24 | 0.36 | ||||||||
| Interest income | 0.32 | 0.58 | 0.58 | 0.65 | 1.46 | 2.05 | 1.85 | |||
| Other non-operating income | -0.2 | 0.01 | 0.5 | 0.38 | 0.36 | 2.04 | 1.98 | 2.87 | 1.45 | 1.45 |
| Pre-tax income | 3.6 | 3.41 | -1.11 | -0.44 | -1.06 | 0.68 | 1.94 | 4.74 | -0.42 | -1.66 |
| Income tax | 1 | 1.16 | 0.88 | -0.07 | 0.38 | 0.44 | 0.05 | -0.47 | -0.09 | -1.57 |
| Income from continuing operations | 2.24 | -1.99 | -0.37 | -1.45 | 0.23 | 1.89 | ||||
| Net income | 2.6 | 2.51 | 14.4 | -0.37 | -1.45 | 0.7 | 1.89 | 5.2 | -0.33 | -0.09 |
| EBITDA | 4.37 | 3.76 | -1.1 | -0.42 | -0.98 | -0.98 | 0.31 | 2.21 | -1.58 | -2.87 |
| EPS, basic | 0.35 | 0.32 | 1.83 | -0.05 | -0.18 | 0.08 | 0.21 | 0.56 | -0.04 | -0.01 |
| EPS, diluted | 0.34 | 0.32 | 1.79 | -0.05 | -0.18 | 0.08 | 0.21 | 0.55 | -0.04 | -0.01 |
| Shares, basic (weighted) | 7.15 | 7.38 | 7.57 | 7.78 | 7.98 | 8.23 | 8.44 | 8.76 | 9.04 | 9.3 |
| Shares, diluted (weighted) | 7.4 | 7.56 | 7.73 | 7.78 | 7.98 | 8.36 | 8.48 | 8.94 | 9.04 | 9.3 |
| Dividend per share | 0.22 | 0.22 | 0.24 | 0.30 | 0.15 | 0.02 | 0.07 | 0.11 | 0.12 |
Balance sheet
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.54 | 10.4 | 25.1 | 18.1 | 19.3 | 20 | 24 | 25.2 | 30.6 | 27.4 |
| Short-term investments | 0 | |||||||||
| Receivables | 19 | 17.7 | 12 | 13 | 14.5 | 12 | ||||
| Inventory | 5.58 | 5.57 | 7.56 | 7.82 | 5.29 | 3.99 | 4.37 | 2.54 | 2.29 | 1.44 |
| Other current assets | 1.59 | 1.08 | 1.88 | 4.65 | 2.54 | 4.62 | 7.04 | 2.48 | 3.09 | 2.52 |
| Total current assets | 41.8 | 50.3 | 48.4 | 46.5 | 41.6 | 49 | 59.5 | 50.4 | 54.8 | 52.3 |
| Property, plant and equipment | 1.68 | 0.92 | 0.85 | 1.27 | 1.05 | 0.76 | 0.65 | 0.53 | 0.43 | 0.54 |
| Lease right-of-use assets | 2.01 | 1.36 | 1.16 | 0.97 | 0.49 | 1.65 | ||||
| Intangible assets | 0.29 | 0.17 | 0.05 | 0.04 | 0.03 | 0.02 | 0.01 | 0.05 | 0.05 | 0.07 |
| Other non-current assets | 0.19 | 0.07 | 0.07 | 0.12 | 0.15 | 0.07 | 0.11 | 0.12 | 0.17 | 0.18 |
| Total assets | 48.7 | 58.9 | 55.3 | 59.4 | 53.6 | 63 | 75.1 | 65.9 | 69.4 | 71.2 |
| Accounts payable | 4.36 | 8.12 | 4.47 | 13.5 | 5.6 | 11.3 | 19.2 | 5.14 | 6.95 | 13.5 |
| Accrued liabilities | 2.14 | 1.53 | 1.84 | 0.99 | 1.02 | 1.23 | 1.61 | 1.96 | 1.34 | 1.42 |
| Deferred revenue | 4.7 | 0.94 | 1.2 | 0.74 | 0.95 | 0.9 | 4.1 | 1.9 | 2.2 | 1.5 |
| Short-term debt | 3.2 | 3.1 | 3.2 | |||||||
| Total current liabilities | 17.4 | 26 | 14.1 | 20 | 13 | 17.8 | 30.2 | 15.7 | 18.7 | 22.2 |
| Long-term debt | 0.68 | 2.49 | 0.88 | 0.45 | 0 | |||||
| Lease liabilities | 1.39 | 0.82 | 0.62 | 0.48 | 0.12 | 1.34 | ||||
| Other non-current liabilities | 0.54 | 0.63 | 0.2 | 4.78 | 3.05 | 1.85 | 1.61 | 1.71 | ||
| Total liabilities | 31.1 | 37.9 | 21.5 | 28.9 | 24.1 | 28.9 | 36.1 | 19.8 | 22.2 | 26.6 |
| Paid-in capital | 12.9 | 13.7 | 14.7 | 15.7 | 17 | 18.3 | 19.5 | 20.8 | 22.7 | 24.7 |
| Retained earnings | 16.6 | 17.4 | 29.9 | 27.2 | 24.5 | 25.2 | 26.8 | 31.3 | 29.8 | 27.7 |
| Treasury stock | -0.97 | |||||||||
| Other comprehensive income | -11.9 | -10.2 | -10.8 | -12.6 | -12 | -9.45 | -7.33 | -6.09 | -5.37 | -7.99 |
| Shareholders' equity | 17.7 | 21 | 33.8 | 30.4 | 29.5 | 34 | 39 | 46.1 | 47.3 | 44.6 |
| Total equity | 17.7 | 21 | 33.8 | 30.4 | 29.5 | 34 | 39 | 46.1 | 47.3 | 44.6 |
| Total liabilities and equity | 48.7 | 58.9 | 55.3 | 59.4 | 53.6 | 63 | 75.1 | 65.9 | 69.4 | 71.2 |
| Shares outstanding | 7.57 | 7.8 | 7.96 | 8.23 | 8.47 | 8.71 | 9.03 | 9.46 | 9.78 | 9.91 |
Cash flow statement
| FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | 2.6 | 2.51 | 14.4 | -0.37 | -1.45 | 0.7 | 1.89 | 5.2 | -0.33 | -0.09 |
| Depreciation and amortization | 0.57 | 0.37 | 0.51 | 0.41 | 0.44 | 0.38 | 0.35 | 0.34 | 0.29 | 0.24 |
| Stock-based compensation | 0.41 | 0.58 | 0.69 | 0.79 | 0.98 | 0.98 | 0.98 | 1.13 | 1.58 | 1.77 |
| Deferred income tax | 0.42 | -0.02 | 0.06 | -0.05 | 0.8 | 1.15 | 0 | -2.35 | -0.39 | -1.74 |
| Change in receivables | 0.03 | -0.03 | -0.04 | 0.05 | 0.04 | 1.08 | -1.57 | 2.47 | ||
| Change in inventory | -0.81 | -0.57 | -2.56 | -0.78 | 2.11 | 1.26 | -0.52 | 1.56 | -0.1 | 0.67 |
| Change in payables | -1.65 | 5.21 | -2.54 | 7.23 | -8.03 | 5.73 | 8.71 | -11.6 | 1.38 | 7.48 |
| Cash from operations | 5 | 2.66 | 2.88 | -3.33 | 0.24 | 1.9 | 2.68 | 3.91 | 4.21 | 2.27 |
| Capital expenditures | -0.74 | -0.21 | -0.44 | -0.83 | -0.23 | -0.1 | -0.23 | -0.23 | -0.2 | -0.35 |
| Purchases of investments | 0 | -3.53 | 0 | |||||||
| Cash from investing | -0.9 | -0.51 | 13.6 | -0.98 | -0.35 | -0.17 | 0.02 | -0.34 | -0.26 | -0.43 |
| Debt repaid | -1.14 | -0.33 | -0.74 | -0.41 | -0.43 | 0 | ||||
| Stock issued | 0.26 | 0.22 | 0.25 | |||||||
| Share buybacks | -0.05 | 0 | -0.17 | -0.01 | -0.1 | -0.87 | ||||
| Dividends paid | -1.67 | -1.72 | -1.92 | -2.47 | -1.26 | 0 | -0.14 | -0.66 | -1.02 | -1.19 |
| Cash from financing | -1.41 | -1.51 | -1.6 | -2.25 | 0.83 | -0.95 | 1.33 | -2.4 | 1.38 | -5.04 |
| Exchange rate effect | -0.78 | 0.14 | -0.24 | 0.43 | -0.04 | -0.05 | 0.07 | 0.03 | 0.03 | |
| Net change in cash | 1.92 | 0.78 | 14.7 | -7.01 | 1.17 | 0.74 | 3.98 | 1.24 | 5.37 | -3.17 |
| Free cash flow | 4.27 | 2.45 | 2.44 | -4.16 | 0.01 | 1.81 | 2.44 | 3.68 | 4.02 | 1.92 |
| Interest paid | 0.09 | 0.08 | 0.07 | 0.07 | 0.28 | 0.19 | 0.18 | 0.31 | 0.21 | 0.14 |
| Income taxes paid | 0.33 | 1.14 | 0.9 | 0.05 | 0.02 | 0.11 | -0.23 | 0.25 | 1.6 | 0.45 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 33.1% | Gross profit / revenue. |
| Operating margin | -5.3% | Operating income / revenue. |
| EBITDA margin | -5.0% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -2.4% | Pre-tax income / revenue. |
| Net margin | -1.2% | Net income / revenue. |
| FCF margin | -2.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | -1.9% | Cash from operations / revenue. |
| Return on equity (ROE) | -1.5% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -1.0% | Net income / average total assets. |
| Return on invested capital (ROIC) | -12.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 6.0% | Research and development expense / revenue. |
| SG&A / revenue | 32.4% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 3.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.6% | Capital expenditures / revenue. |
| D&A / revenue | 0.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 6.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 2.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -1.0% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -1.8% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -0.6% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | 1.5% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -46.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -5.4% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 56.2% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -52.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -7.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 167.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Dividend per share growth, 1y | 14.3% | Dividend per share vs the same period a year earlier. Only from a positive base. |
| Dividend per share CAGR, 3y | 99.6% | Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Dividend per share CAGR, 5y | -4.5% | Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -5.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 4.6% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 8.6% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 2.5% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -1.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 5.8% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 2.8% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 3.1% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 3.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.40x | Current assets / current liabilities. |
| Quick ratio | 1.76x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 1.20x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 37.5% | Total liabilities / total assets. |
| Interest coverage | -5.29x | Operating income / interest expense. |
| Working capital | $28.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 0.1% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $44.2M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.80x | Revenue / average total assets. |
| Fixed asset turnover | 117x | Revenue / average property, plant and equipment. |
| Inventory turnover | 20.8x | Cost of revenue / average inventory. |
| Days inventory | 18 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.01x | Revenue / average receivables. |
| Days sales outstanding | 73 days | 365 x average receivables / revenue. |
| Days payables | 148 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | -57 days | Days inventory + days sales outstanding - days payables. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$0.07 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $5.95 | Revenue / diluted weighted shares. |
| FCF per share | -$0.15 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | -$0.11 | Cash from operations / diluted weighted shares. |
| Book value per share | $4.40 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $4.39 | Tangible book value / shares outstanding. |
| Cash per share | $2.45 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $77.7M | Share price x shares outstanding. |
| Enterprise value | $53.1M | Market cap + total debt - cash - short-term investments. |
| P/S | 1.37x | Market cap / revenue. |
| P/B | 1.76x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 1.76x | Market cap / tangible book value, when positive. |
| EV/Sales | 0.93x | Enterprise value / revenue. |
| FCF yield | -1.8% | Free cash flow / market cap. |
| Earnings yield | -0.9% | Net income / market cap (the inverse of P/E). |
What was CSP INC /MA/'s revenue in fiscal 2025?
CSP INC /MA/ reported revenue of $58.7M for fiscal 2025, 6.4% higher than the year before.
Was CSP INC /MA/ profitable in fiscal 2025?
No. It reported a net loss of $91.0K.
How much free cash flow did CSP INC /MA/ generate in fiscal 2025?
Cash from operations of $2.3M minus capital expenditures of $348.0K left free cash flow of $1.9M.